Global AT1 Receptor Antagonists Market 2020-2026 Report by Type Applications Manufacturers and Regional Overview

Report Description

The Global AT1 Receptor Antagonists Market study is major compilation of significant information with respect to the competitor details of this market. Likewise, the information is also inclusive of the several regions where the global AT1 Receptor Antagonists market has successfully gained the position. This research report evaluates the global AT1 Receptor Antagonists market growth rate and the industry value on the basis of growth inducing factors, market dynamics, and other related data. The data offered in this report is gathered based on the latest industry news, trends, as well as opportunities. Moreover, the report comprises a complete market analysis and provider landscape with the help of SWOT analysis of the major service providers. This research report provides an extensive evaluation of the global AT1 Receptor Antagonists industry.

A research report on the global AT1 Receptor Antagonists market offers a detailed analysis about the market share, size, trends, and growth prospects. In addition, the report contains market volume with an accurate estimation offered in the report. The report is designed through the detailed qualitative insights, verifiable projections, and historical data about the global AT1 Receptor Antagonists market size. The AT1 Receptor Antagonists market study also sheds light on the highly lucrative market opportunities that influences the growth of the market. Moreover, the study offers a complete analysis of the market size, segmentation, and market share. Additionally, the report contains market dynamics such as market restraints, growth drivers, opportunities, service providers, stakeholders, investors, key market players, profile assessment, and challenges of the global AT1 Receptor Antagonists market.

Likewise, the AT1 Receptor Antagonists market report also features a comprehensive quantitative and qualitative evaluation by analyzing information collected from market experts and industry participants in the major points of the market value chain. This study offers a separate analysis of the major trends in the existing market, mandates and regulations, micro macroeconomic indicators is also comprised in this report. By doing so, the study estimated the attractiveness of every major segment during the prediction period. The report delivers core insights regarding the AT1 Receptor Antagonists market report with an in-depth study of market size, country-level market size, region, segmentation market growth, market share, sales analysis, value chain optimization, market players, the competitive landscape, recent developments, product launches, strategic market growth analysis, trade regulations, opportunities analysis, and technological innovations.

Moreover, the AT1 Receptor Antagonists market report introduced the market through several factors such as classifications, definitions, market overview, product specifications, cost structures, manufacturing processes, raw materials, and applications. It also includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. In addition, this report offers significant data through the SWOT analysis, investment return data, and investment feasibility analysis. Likewise, the global AT1 Receptor Antagonists market report offers some presentations and illustrations about the market that comprises pie charts, graphs, and charts which presents the percentage of the various strategies implemented by the service providers in the global AT1 Receptor Antagonists market. In addition to this, the report has been designed through the complete surveys, primary research interviews, as well as observations, and secondary research.

Table of Content

1 Study Coverage
1.1 AT1 Receptor Antagonists Product Introduction
1.2 Market Segments
1.3 Key AT1 Receptor Antagonists Manufacturers Covered Ranking by Revenue
1.4 Market by Type
1.4.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global AT1 Receptor Antagonists Market Size, Estimates and Forecasts
2.1.1 Global AT1 Receptor Antagonists Revenue 2015-2026
2.1.2 Global AT1 Receptor Antagonists Sales 2015-2026
2.2 Global AT1 Receptor Antagonists, Market Size by Producing Regions 2015 VS 2020 VS 2026
2.2.1 Global AT1 Receptor Antagonists Retrospective Market Scenario in Sales by Region 2015-2020
2.2.2 Global AT1 Receptor Antagonists Retrospective Market Scenario in Revenue by Region 2015-2020

3 Global AT1 Receptor Antagonists Competitor Landscape by Players
3.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 AT1 Receptor Antagonists Sales by Manufacturers (2015-2020)
3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers (2015-2020)
3.2 AT1 Receptor Antagonists Revenue by Manufacturers
3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2015-2020)
3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
3.2.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by AT1 Receptor Antagonists Revenue in 2019
3.2.5 Global AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 AT1 Receptor Antagonists Price by Manufacturers
3.4 AT1 Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers AT1 Receptor Antagonists Product Type
3.4.3 Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
3.5 Manufacturers Mergers Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global AT1 Receptor Antagonists Market Size by Type (2015-2020)
4.1.1 Global AT1 Receptor Antagonists Sales by Type (2015-2020)
4.1.2 Global AT1 Receptor Antagonists Revenue by Type (2015-2020)
4.1.3 AT1 Receptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
4.2 Global AT1 Receptor Antagonists Market Size Forecast by Type (2021-2026)
4.2.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2021-2026)
4.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Type (2021-2026)
4.2.3 AT1 Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global AT1 Receptor Antagonists Market Share by Price Tier (2015-2020) Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global AT1 Receptor Antagonists Market Size by Application (2015-2020)
5.1.1 Global AT1 Receptor Antagonists Sales by Application (2015-2020)
5.1.2 Global AT1 Receptor Antagonists Revenue by Application (2015-2020)
5.1.3 AT1 Receptor Antagonists Price by Application (2015-2020)
5.2 AT1 Receptor Antagonists Market Size Forecast by Application (2021-2026)
5.2.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2021-2026)
5.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Application (2021-2026)
5.2.3 Global AT1 Receptor Antagonists Price Forecast by Application (2021-2026)

6 North America
6.1 North America AT1 Receptor Antagonists by Country
6.1.1 North America AT1 Receptor Antagonists Sales by Country
6.1.2 North America AT1 Receptor Antagonists Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America AT1 Receptor Antagonists Market Facts Figures by Type
6.3 North America AT1 Receptor Antagonists Market Facts Figures by Application

7 Europe
7.1 Europe AT1 Receptor Antagonists by Country
7.1.1 Europe AT1 Receptor Antagonists Sales by Country
7.1.2 Europe AT1 Receptor Antagonists Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe AT1 Receptor Antagonists Market Facts Figures by Type
7.3 Europe AT1 Receptor Antagonists Market Facts Figures by Application

8 Asia Pacific
8.1 Asia Pacific AT1 Receptor Antagonists by Region
8.1.1 Asia Pacific AT1 Receptor Antagonists Sales by Region
8.1.2 Asia Pacific AT1 Receptor Antagonists Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific AT1 Receptor Antagonists Market Facts Figures by Type
8.3 Asia Pacific AT1 Receptor Antagonists Market Facts Figures by Application

9 Latin America
9.1 Latin America AT1 Receptor Antagonists by Country
9.1.1 Latin America AT1 Receptor Antagonists Sales by Country
9.1.2 Latin America AT1 Receptor Antagonists Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central South America AT1 Receptor Antagonists Market Facts Figures by Type
9.3 Central South America AT1 Receptor Antagonists Market Facts Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa AT1 Receptor Antagonists by Country
10.1.1 Middle East and Africa AT1 Receptor Antagonists Sales by Country
10.1.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa AT1 Receptor Antagonists Market Facts Figures by Type
10.3 Middle East and Africa AT1 Receptor Antagonists Market Facts Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer AT1 Receptor Antagonists Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AT1 Receptor Antagonists Products Offered
11.2.5 Novartis Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck AT1 Receptor Antagonists Products Offered
11.3.5 Merck Related Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Corporation Information
11.4.2 Astra Zeneca Description and Business Overview
11.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Astra Zeneca AT1 Receptor Antagonists Products Offered
11.4.5 Astra Zeneca Related Developments
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Corporation Information
11.5.2 Jhonson and Johnson Description and Business Overview
11.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Jhonson and Johnson AT1 Receptor Antagonists Products Offered
11.5.5 Jhonson and Johnson Related Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Description and Business Overview
11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly AT1 Receptor Antagonists Products Offered
11.6.5 Eli Lilly Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi AT1 Receptor Antagonists Products Offered
11.7.5 Sanofi Related Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Description and Business Overview
11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Products Offered
11.8.5 Bristol-Myers Squibb Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer AT1 Receptor Antagonists Products Offered
11.9.5 Bayer Related Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Description and Business Overview
11.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GSK AT1 Receptor Antagonists Products Offered
11.10.5 GSK Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer AT1 Receptor Antagonists Products Offered
11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 AT1 Receptor Antagonists Market Estimates and Projections by Region
12.1.1 Global AT1 Receptor Antagonists Sales Forecast by Regions 2021-2026
12.1.2 Global AT1 Receptor Antagonists Revenue Forecast by Regions 2021-2026
12.2 North America AT1 Receptor Antagonists Market Size Forecast (2021-2026)
12.2.1 North America AT1 Receptor Antagonists Sales Forecast (2021-2026)
12.2.2 North America AT1 Receptor Antagonists Revenue Forecast (2021-2026)
12.2.3 North America AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.3 Europe AT1 Receptor Antagonists Market Size Forecast (2021-2026)
12.3.1 Europe AT1 Receptor Antagonists Sales Forecast (2021-2026)
12.3.2 Europe AT1 Receptor Antagonists Revenue Forecast (2021-2026)
12.3.3 Europe AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific AT1 Receptor Antagonists Market Size Forecast (2021-2026)
12.4.1 Asia Pacific AT1 Receptor Antagonists Sales Forecast (2021-2026)
12.4.2 Asia Pacific AT1 Receptor Antagonists Revenue Forecast (2021-2026)
12.4.3 Asia Pacific AT1 Receptor Antagonists Market Size Forecast by Region (2021-2026)
12.5 Latin America AT1 Receptor Antagonists Market Size Forecast (2021-2026)
12.5.1 Latin America AT1 Receptor Antagonists Sales Forecast (2021-2026)
12.5.2 Latin America AT1 Receptor Antagonists Revenue Forecast (2021-2026)
12.5.3 Latin America AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa AT1 Receptor Antagonists Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa AT1 Receptor Antagonists Sales Forecast (2021-2026)
12.6.2 Middle East and Africa AT1 Receptor Antagonists Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa AT1 Receptor Antagonists Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key AT1 Receptor Antagonists Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 AT1 Receptor Antagonists Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. AT1 Receptor Antagonists Market Segments
Table 2. Ranking of Global Top AT1 Receptor Antagonists Manufacturers by Revenue (US Million) in 2019
Table 3. Global AT1 Receptor Antagonists Market Size Growth Rate by Type 2020-2026 (K Units) (US Million)
Table 4. Major Manufacturers of Valsartan
Table 5. Major Manufacturers of Telmisartan
Table 6. Major Manufacturers of Losartan
Table 7. Major Manufacturers of Irbesartan
Table 8. Major Manufacturers of Azilsartan
Table 9. Major Manufacturers of Olmesartan
Table 10. Global AT1 Receptor Antagonists Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global AT1 Receptor Antagonists Market Size by Region (K Units) (US Million) 2020 VS 2026
Table 12. Global AT1 Receptor Antagonists Sales by Regions 2015-2020 (K Units)
Table 13. Global AT1 Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 14. Global AT1 Receptor Antagonists Revenue by Regions 2015-2020 (US Million)
Table 15. Global AT1 Receptor Antagonists Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global AT1 Receptor Antagonists Sales Share by Manufacturers (2015-2020)
Table 17. Global AT1 Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AT1 Receptor Antagonists as of 2019)
Table 19. AT1 Receptor Antagonists Revenue by Manufacturers (2015-2020) (US Million)
Table 20. AT1 Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers AT1 Receptor Antagonists Price (2015-2020) (USD/Unit)
Table 22. AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers AT1 Receptor Antagonists Product Type
Table 24. Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
Table 25. Manufacturers Mergers Acquisitions, Expansion Plans
Table 26. Global AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 27. Global AT1 Receptor Antagonists Sales Share by Type (2015-2020)
Table 28. Global AT1 Receptor Antagonists Revenue by Type (2015-2020) (US Million)
Table 29. Global AT1 Receptor Antagonists Revenue Share by Type (2015-2020)
Table 30. AT1 Receptor Antagonists Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 32. Global AT1 Receptor Antagonists Sales Share by Application (2015-2020)
Table 33. North America AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 34. North America AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 35. North America AT1 Receptor Antagonists Revenue by Country (2015-2020) (US Million)
Table 36. North America AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 37. North America AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 38. North America AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 39. North America AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 40. North America AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 41. Europe AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 42. Europe AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 43. Europe AT1 Receptor Antagonists Revenue by Country (2015-2020) (US Million)
Table 44. Europe AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 45. Europe AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 46. Europe AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 47. Europe AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 48. Europe AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific AT1 Receptor Antagonists Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific AT1 Receptor Antagonists Revenue by Region (2015-2020) (US Million)
Table 52. Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 57. Latin America AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 58. Latin America AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa AT1 Receptor Antagonists Revenue by Country (2015-2020) (US Million)
Table 60. Latin America AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 61. Latin America AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 62. Latin America AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 63. Latin America AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 64. Latin America AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa AT1 Receptor Antagonists Revenue by Country (2015-2020) (US Million)
Table 68. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Major Businesses
Table 75. Pfizer AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Pfizer Product
Table 77. Pfizer Recent Development
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Major Businesses
Table 80. Novartis AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Product
Table 82. Novartis Recent Development
Table 83. Merck Corporation Information
Table 84. Merck Description and Major Businesses
Table 85. Merck AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merck Product
Table 87. Merck Recent Development
Table 88. Astra Zeneca Corporation Information
Table 89. Astra Zeneca Description and Major Businesses
Table 90. Astra Zeneca AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Astra Zeneca Product
Table 92. Astra Zeneca Recent Development
Table 93. Jhonson and Johnson Corporation Information
Table 94. Jhonson and Johnson Description and Major Businesses
Table 95. Jhonson and Johnson AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Jhonson and Johnson Product
Table 97. Jhonson and Johnson Recent Development
Table 98. Eli Lilly Corporation Information
Table 99. Eli Lilly Description and Major Businesses
Table 100. Eli Lilly AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Eli Lilly Product
Table 102. Eli Lilly Recent Development
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Major Businesses
Table 105. Sanofi AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Sanofi Product
Table 107. Sanofi Recent Development
Table 108. Bristol-Myers Squibb Corporation Information
Table 109. Bristol-Myers Squibb Description and Major Businesses
Table 110. Bristol-Myers Squibb AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Bristol-Myers Squibb Product
Table 112. Bristol-Myers Squibb Recent Development
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bayer Product
Table 117. Bayer Recent Development
Table 118. GSK Corporation Information
Table 119. GSK Description and Major Businesses
Table 120. GSK AT1 Receptor Antagonists Production (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. GSK Product
Table 122. GSK Recent Development
Table 123. Teva Pharmaceutical Corporation Information
Table 124. Teva Pharmaceutical Description and Major Businesses
Table 125. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K Units), Revenue (US Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Teva Pharmaceutical Product
Table 127. Teva Pharmaceutical Recent Development
Table 128. Global AT1 Receptor Antagonists Sales Forecast by Regions (2021-2026) (K Units)
Table 129. Global AT1 Receptor Antagonists Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global AT1 Receptor Antagonists Revenue Forecast by Regions (2021-2026) (US Million)
Table 131. Global AT1 Receptor Antagonists Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America AT1 Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 133. North America AT1 Receptor Antagonists Revenue Forecast by Country (2021-2026) (US Million)
Table 134. Europe AT1 Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 135. Europe AT1 Receptor Antagonists Revenue Forecast by Country (2021-2026) (US Million)
Table 136. Asia Pacific AT1 Receptor Antagonists Sales Forecast by Region (2021-2026) (K Units)
Table 137. Asia Pacific AT1 Receptor Antagonists Revenue Forecast by Region (2021-2026) (US Million)
Table 138. Latin America AT1 Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 139. Latin America AT1 Receptor Antagonists Revenue Forecast by Country (2021-2026) (US Million)
Table 140. Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Country (2021-2026) (K Units)
Table 141. Middle East and Africa AT1 Receptor Antagonists Revenue Forecast by Country (2021-2026) (US Million)
Table 142. Key Opportunities and Drivers Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key AT1 Receptor Antagonists Players
Table 146. AT1 Receptor Antagonists Customers List
Table 147. AT1 Receptor Antagonists Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. AT1 Receptor Antagonists Product Picture
Figure 2. Global AT1 Receptor Antagonists Sales Market Share by Type in 2020 2026
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global AT1 Receptor Antagonists Sales Market Share by Application in 2020 2026
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. AT1 Receptor Antagonists Report Years Considered
Figure 15. Global AT1 Receptor Antagonists Market Size 2015-2026 (US Million)
Figure 16. Global AT1 Receptor Antagonists Sales 2015-2026 (K Units)
Figure 17. Global AT1 Receptor Antagonists Market Size Market Share by Region 2020 Versus 2026
Figure 18. Global AT1 Receptor Antagonists Sales Market Share by Region (2015-2020)
Figure 19. Global AT1 Receptor Antagonists Sales Market Share by Region in 2019
Figure 20. Global AT1 Receptor Antagonists Revenue Market Share by Region (2015-2020)
Figure 21. Global AT1 Receptor Antagonists Revenue Market Share by Region in 2019
Figure 22. Global AT1 Receptor Antagonists Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by AT1 Receptor Antagonists Revenue in 2019
Figure 24. AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2015 VS 2019
Figure 25. Global AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Figure 26. Global AT1 Receptor Antagonists Sales Market Share by Type in 2019
Figure 27. Global AT1 Receptor Antagonists Revenue Market Share by Type (2015-2020)
Figure 28. Global AT1 Receptor Antagonists Revenue Market Share by Type in 2019
Figure 29. Global AT1 Receptor Antagonists Market Share by Price Range (2015-2020)
Figure 30. Global AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Figure 31. Global AT1 Receptor Antagonists Sales Market Share by Application in 2019
Figure 32. Global AT1 Receptor Antagonists Revenue Market Share by Application (2015-2020)
Figure 33. Global AT1 Receptor Antagonists Revenue Market Share by Application in 2019
Figure 34. North America AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US Million)
Figure 36. North America AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 37. North America AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 38. U.S. AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 40. Canada AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 42. North America AT1 Receptor Antagonists Market Share by Type in 2019
Figure 43. North America AT1 Receptor Antagonists Market Share by Application in 2019
Figure 44. Europe AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US Million)
Figure 46. Europe AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 47. Europe AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 48. Germany AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 50. France AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 51. France AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 52. U.K. AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 54. Italy AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 56. Russia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 58. Europe AT1 Receptor Antagonists Market Share by Type in 2019
Figure 59. Europe AT1 Receptor Antagonists Market Share by Application in 2019
Figure 60. Asia Pacific AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US Million)
Figure 62. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Region in 2019
Figure 63. Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Region in 2019
Figure 64. China AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 65. China AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 66. Japan AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 68. South Korea AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 70. India AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 71. India AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 72. Australia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 74. Taiwan AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 76. Indonesia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 78. Thailand AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 80. Malaysia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 82. Philippines AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 84. Vietnam AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 86. Asia Pacific AT1 Receptor Antagonists Market Share by Type in 2019
Figure 87. Asia Pacific AT1 Receptor Antagonists Market Share by Application in 2019
Figure 88. Latin America AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US Million)
Figure 90. Latin America AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 91. Latin America AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 92. Mexico AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 94. Brazil AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 96. Argentina AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 98. Latin America AT1 Receptor Antagonists Market Share by Type in 2019
Figure 99. Latin America AT1 Receptor Antagonists Market Share by Application in 2019
Figure 100. Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US Million)
Figure 102. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 103. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 104. Turkey AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 106. Saudi Arabia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 108. U.A.E AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US Million)
Figure 110. Middle East and Africa AT1 Receptor Antagonists Market Share by Type in 2019
Figure 111. Middle East and Africa AT1 Receptor Antagonists Market Share by Application in 2019
Figure 112. North America AT1 Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America AT1 Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US Million)
Figure 114. Europe AT1 Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe AT1 Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US Million)
Figure 116. Asia Pacific AT1 Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US Million)
Figure 118. Latin America AT1 Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America AT1 Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US Million)
Figure 120. Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate Forecast (2021-2026) (US Million)
Figure 122. Porters Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed